This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Phytohealth Corporation. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations of Chien-Hsin Cheng in Medicinal Chemistry
Introduction
Chien-Hsin Cheng is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that address renal and cardiac dysfunction.
Latest Patents
Chien-Hsin Cheng holds a patent for a compound known as Medicarpin and its derivatives. This patent outlines a manufacturing method for the compound, which is designed to treat renal and cardiac dysfunction. The compound's formula is defined in the specification, and it includes a method for administering an effective amount of the compound along with a pharmaceutical acceptable salt and carrier.
Career Highlights
Chien-Hsin Cheng is associated with Phytohealth Corporation, where he continues to innovate in the field of medicinal compounds. His work has the potential to impact the treatment of serious health conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Chien-Hsin Cheng has collaborated with notable colleagues such as Kuo-Hsiung Lee and Rong-Tsun Wu. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Chien-Hsin Cheng's work exemplifies the importance of innovation in medicinal chemistry, particularly through his patent on Medicarpin. His contributions are paving the way for new treatments that could significantly benefit patients with renal and cardiac issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile